Inhibiting the protein ovary testis transcribed involves a multifaceted approach targeting various cellular signaling pathways and enzymatic activities. The inhibitors Staurosporine, LY294002, Wortmannin, Dasatinib, Erlotinib, Imatinib, and Lapatinib are key players in this process due to their roles in targeting specific proteins and pathways that regulate or influence the activity of ovary testis transcribed. Staurosporine's broad-spectrum inhibition of protein kinases can prevent phosphorylation, an essential post-translational modification necessary for the activation or functional modification of ovary testis transcribed. LY294002 and Wortmannin, both PI3K inhibitors, disrupt signaling pathways critical for the activity of ovary testis transcribed, leading to its functional inhibition. This disruption illustrates the significance of the PI3K pathway in regulating processes that ovary testis transcribed may be involved in.
Furthermore, Rapamycin targets the mTOR pathway, directly impacting protein synthesis and cellular growth processes, vital for ovary testis transcribed's function or post-translational modifications. Inhibitors like PD98059, SB203580, SP600125, and U0126, which target the MAPK/ERK, p38 MAPK, and JNK pathways, respectively, are involved in various cellular processes, including stress responses and regulation, likely important for ovary testis transcribed's functionality. By inhibiting these pathways, these chemicals lead to a decrease in the functional activity of ovary testis transcribed. Erlotinib, Imatinib, and Lapatinib, as tyrosine kinase inhibitors, further contribute to the inhibition by targeting EGFR, BCR-ABL, c-Kit, PDGFR, and HER2/neu. The inhibition of these kinases leads to a reduction in the functional activity of ovary testis transcribed by disrupting the signaling cascades crucial for its functional state. The collective action of these inhibitors, through their specific targets, contributes to the functional inhibition of ovary testis transcribed, demonstrating the intricate interplay between cellular signaling pathways and protein functionality.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine inhibits protein kinases, likely impacting the phosphorylation essential for ovary testis transcribed's activation or functional modification. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, disrupting signaling pathways crucial for ovary testis transcribed's activity, leading to functional inhibition. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mTOR pathway, impacting protein synthesis and growth processes vital for ovary testis transcribed's function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK in the MAPK/ERK pathway, potentially reducing ovary testis transcribed's activity by lowering ERK activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, affecting stress response pathways and reducing ovary testis transcribed's functional activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, impacting cellular processes and reducing ovary testis transcribed's functional activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2 in the MAPK/ERK pathway, potentially reducing ovary testis transcribed's activity by affecting downstream targets. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3K inhibitor, disrupts signaling pathways, leading to functional inhibition of ovary testis transcribed. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib inhibits tyrosine kinases, reducing ovary testis transcribed's activity by affecting relevant signaling pathways. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Erlotinib inhibits EGFR tyrosine kinase, essential for ovary testis transcribed's function, leading to reduced activity. | ||||||